Get Instant Summarized Text (Gist) The study provides new insights into the behavior of cells in the eye's drainage system, which could inform glaucoma treatments. It reveals that changes in the ...

The Tube's crime epidemic was laid bare this week after photos emerged of a 'dirty, scuffy-looking' male lighting a metal pipe on a carriage. Phlegming at the mouth and spitting on the floor ...

The eyedrop is an option for those who are benefitting from preservative-free eye drops. Credit: Andrey Sayfutdinov/Shutterstock. China’s National Medical Products ...

shared her excitement about the positive VisiPlate® performance in Ultrathin Shunt Shows Promising Results in Trial, an article by Jim Gallagher, Senior Managing Editor at Glaucoma Physician.

Baseline intraocular pressure (IOP) of the cohort averaged 24.1 mmHg (ranging from 18.8 mmHg to 40.2 mmHg), with the study eyes requiring an average of 2.0 glaucoma ... shunt is a unique design ...

The VisiPlate® device demonstrated a favorable safety profile with no subject losing ≥2 lines of best-corrected visual acuity (BCVA), and no need for device removal or additional glaucoma procedures.